دورية أكاديمية

A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial.

التفاصيل البيبلوغرافية
العنوان: A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial.
المؤلفون: Williams EV; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Goranitis I; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Oppong R; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Perry SJ; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Devall AJ; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Martin JT; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Mammoliti KM; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Beeson LE; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Sindhu KN; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Galadanci H; African Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria., Alwy Al-Beity F; Department of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Qureshi Z; Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya., Hofmeyr GJ; Effective Care Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Department of Obstetrics and Gynecology, University of Botswana, Gaborone, Botswana., Moran N; KwaZulu-Natal Department of Health, Pietermaritzburg, South Africa., Fawcus S; Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa., Mandondo S; Eastern Cape Department of Health, Bhisho, South Africa.; Department of Obstetrics and Gynaecology, Walter Sisulu University, Mthatha, South Africa., Middleton L; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Hemming K; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Oladapo OT; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland., Gallos ID; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland., Coomarasamy A; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Roberts TE; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. t.e.roberts@bham.ac.uk.
المصدر: Nature medicine [Nat Med] 2024 Jun 06. Date of Electronic Publication: 2024 Jun 06.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
أسماء مطبوعة: Publication: New York Ny : Nature Publishing Company
Original Publication: New York, NY : Nature Pub. Co., [1995-
مستخلص: Timely detection and treatment of postpartum hemorrhage (PPH) are crucial to prevent complications or death. A calibrated blood-collection drape can help provide objective, accurate and early diagnosis of PPH, and a treatment bundle can address delays or inconsistencies in the use of effective interventions. Here we conducted an economic evaluation alongside the E-MOTIVE trial, an international, parallel cluster-randomized trial with a baseline control phase involving 210,132 women undergoing vaginal delivery across 78 secondary-level hospitals in Kenya, Nigeria, South Africa and Tanzania. We aimed to assess the cost-effectiveness of the E-MOTIVE intervention, which included a calibrated blood-collection drape for early detection of PPH and a bundle of first-response treatments (uterine massage, oxytocic drugs, tranexamic acid, intravenous fluids, examination and escalation), compared with usual care. We used multilevel modeling to estimate incremental cost-effectiveness ratios from the perspective of the public healthcare system for outcomes of cost per severe PPH (blood loss ≥1,000 ml) avoided and cost per disability-adjusted life-year averted. Our findings suggest that the use of a calibrated blood-collection drape for early detection of PPH and bundled first-response treatment is cost-effective and should be perceived by decision-makers as a worthwhile use of healthcare budgets. ClinicalTrials.gov identifier: NCT04341662 .
(© 2024. The Author(s).)
References: Kassebaum, N. J. et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 980–1004 (2014). (PMID: 10.1016/S0140-6736(14)60696-6247975754255481)
Sheldon, W. R. et al. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 121, 5–13 (2014). (PMID: 10.1111/1471-0528.1263624641530)
Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health 2, e323–e333 (2014). (PMID: 10.1016/S2214-109X(14)70227-X25103301)
Theunissen, F. et al. Cost of hospital care of women with postpartum haemorrhage in India, Kenya, Nigeria and Uganda: a financial case for improved prevention. Reprod. Health 18, 18 (2021). (PMID: 10.1186/s12978-020-01063-x334828587821537)
Kes, A. et al. The economic burden of maternal mortality on households: evidence from three sub-counties in rural western Kenya. Reprod. Health 12, S3 (2015). (PMID: 10.1186/1742-4755-12-S1-S3260009534423575)
Molla, M., Mitiku, I., Worku, A. & Yamin, A. Impacts of maternal mortality on living children and families: a qualitative study from Butajira, Ethiopia. Reprod. Health 12, S6 (2015). (PMID: 10.1186/1742-4755-12-S1-S6260012764423766)
Bazile, J. et al. Intergenerational impacts of maternal mortality: qualitative findings from rural Malawi. Reprod. Health 12, S1 (2015). (PMID: 10.1186/1742-4755-12-S1-S1260007334423580)
WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage (World Health Organization, 2012).
Vogel, J. P., Oladapo, O. T., Dowswell, T. & Gülmezoglu, A. M. Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage. Lancet Glob. Health 6, e18–e19 (2018). (PMID: 10.1016/S2214-109X(17)30428-X29100880)
Hancock, A., Weeks, A. D. & Lavender, D. T. Is accurate and reliable blood loss estimation the ‘crucial step’ in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth 15, 230 (2015). (PMID: 10.1186/s12884-015-0653-6264159524587838)
Althabe, F. et al. Postpartum hemorrhage care bundles to improve adherence to guidelines: a WHO technical consultation. Int J. Gynaecol. Obstet. 148, 290–299 (2020). (PMID: 10.1002/ijgo.1302831709527)
Forbes, G. et al. Factors influencing postpartum haemorrhage detection and management and the implementation of a new postpartum haemorrhage care bundle (E-MOTIVE) in Kenya, Nigeria, and South Africa. Implement. Sci. 18, 1 (2023). (PMID: 10.1186/s13012-022-01253-0366318219832403)
Akter, S. et al. Detection and management of postpartum haemorrhage: qualitative evidence on healthcare providers’ knowledge and practices in Kenya, Nigeria, and South Africa. Front. Glob. Women’s Health 3, 1020163 (2022). (PMID: 10.3389/fgwh.2022.1020163)
Gallos, I. et al. Randomized trial of early detection and treatment of postpartum hemorrhage. N. Engl. J. Med. 389, 11–21 (2023). (PMID: 10.1056/NEJMoa230396637158447)
Singata-Madliki, M. & Hofmeyr, G. J. A novel, re-usable ‘Safe birth Tray’ for postpartum blood loss monitoring: a preliminary acceptability assessment. Int. J. Gynaecol. Obstet. 155, 553–555 (2021). (PMID: 10.1002/ijgo.1381734227106)
Ramsey, S. D. et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health 18, 161–172 (2015). (PMID: 10.1016/j.jval.2015.02.00125773551)
Wilkinson, T. et al. The international decision support initiative reference case for economic evaluation: an aid to thought. Value Health 19, 921–928 (2016). (PMID: 10.1016/j.jval.2016.04.01527987641)
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disability Weights (Institute for Health Metrics and Evaluation, 2020).
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Life Tables 1950–2019 (Institute for Health Metrics and Evaluation, 2020).
Uses of Medicines for Prevention and Treatment of Post-partum Hemorrhage and Other Obstetric Purposes (United States Agency for International Development, 2022).
International Medical Product Price Guide (Management Sciences for Health, 2015).
Mulligan, J.-A. et al. Unit costs of health care inputs in low and middle income regions. Disease control priorities project working paper. LSHTM Research Online http://researchonline.lshtm.ac.uk/12952/ (LSHTM, 2005).
WHO-CHOICE Estimates of Cost for Inpatient and Outpatient Health Service Delivery (World Health Organization, 2021).
Stenberg, K., Lauer, J. A., Gkountouras, G., Fitzpatrick, C. & Stanciole, A. Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery. Cost. Eff. Resour. Alloc. 16, 11 (2018). (PMID: 10.1186/s12962-018-0095-x295598555858135)
Salary Scales, with Translation Keys, for Employees on Salary Levels 1 to 12 and Those Employees Covered by Occupation Specific Dispensions (OSDs) (Department of Public Service and Administration, 2023).
UNICEF Supply Catalogue Vol. 2023 (UNICEF Supply Division, 2023).
Mvundura, M. et al. Cost-effectiveness of condom uterine balloon tamponade to control severe postpartum hemorrhage in Kenya. Int J. Gynaecol. Obstet. 137, 185–191 (2017). (PMID: 10.1002/ijgo.1212528190262)
Uniform Patient Fee Schedule 2022 Vol. 2023 (National Department of Health, 2022).
Theron, G. B. Management of postpartum hemorrhage with free-flow pressure controlled uterine balloon. Int J. Gynaecol. Obstet. 142, 371–373 (2018). (PMID: 10.1002/ijgo.1253329779208)
Dayananda, K. et al. Selective non-operative management of abdominal stab wounds is a safe and cost effective strategy: a South African experience. Ann. R. Coll. Surg. Engl. 99, 490–496 (2017). (PMID: 10.1308/rcsann.2017.0075286608195696983)
Kumaranayake, L. The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 15, 230–234 (2000). (PMID: 10.1093/heapol/15.2.23010837047)
Gomes, M. et al. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med. Decis. Mak. 32, 350–361 (2012). (PMID: 10.1177/0272989X11418372)
Manca, A., Sculpher, M. J. & Goeree, R. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics 28, 1079–1096 (2010). (PMID: 10.2165/11537760-000000000-0000021080734)
Manca, A., Rice, N., Sculpher, M. J. & Briggs, A. H. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ. 14, 471–485 (2005). (PMID: 10.1002/hec.91415386662)
Thompson, J., Davey, C., Hayes, R., Hargreaves, J. & Fielding, K. swpermute: permutation tests for stepped-wedge cluster-randomised trials. Stata J. 19, 803–819 (2019). (PMID: 10.1177/1536867X19893624325657467305031)
Woods, B., Revill, P., Sculpher, M. & Claxton, K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health 19, 929–935 (2016). (PMID: 10.1016/j.jval.2016.02.017279876425193154)
The World Health Report 2002: Reducing Risks, Promoting Healthy Life (World Health Organization, 2002).
GDP per Capita (Current US$) (The World Bank, 2023).
Fenwick, E., Claxton, K. & Sculpher, M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 10, 779–787 (2001). (PMID: 10.1002/hec.63511747057)
معلومات مُعتمدة: 001 International WHO_ World Health Organization; INV-001393 United States GATES Bill & Melinda Gates Foundation
سلسلة جزيئية: ClinicalTrials.gov NCT04341662
تواريخ الأحداث: Date Created: 20240606 Latest Revision: 20240720
رمز التحديث: 20240720
DOI: 10.1038/s41591-024-03069-5
PMID: 38844798
قاعدة البيانات: MEDLINE
الوصف
تدمد:1546-170X
DOI:10.1038/s41591-024-03069-5